
AI maps brain waste-clearing flow, revealing two speeds tied to deep sleep
Kelley and his colleagues from the University of Rochester, Brown University, and the University of Copenhagen turned to artificial intelligence for help.

Kelley and his colleagues from the University of Rochester, Brown University, and the University of Copenhagen turned to artificial intelligence for help.

SINGAPORE, May 27, 2026 /PRNewswire/ — Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to SPOT-MAS 10, its multi-omic blood test designed to detect cancer-associated signals.

Spectral AI announced that the U.S. Food and Drug Administration (FDA) has granted De Novo classification for its DeepView System, authorizing the company to commence commercial distribution activities in the United States.

California-based Subtle Medical has announced FDA clearance for SubtleHD(PET), its next-generation PET image enhancement solution designed to improve image quality and accelerate PET imaging workflows across PET/CT and PET/MR systems.

Chicago, Illinois-based Cardiosense announced that the US Food and Drug Administration (FDA) has granted De Novo classification for its PCWP Analysis Software, which is designed to estimate noninvasively pulmonary capillary wedge pressure (PCWP), a key indicator of heart health.

A new map of the human eye made using donated eyeballs that could help explain and possibly prevent a handful of sight-related diseases.

DNA can be exchanged between two cells that connect by forming nanotubes, and find out why this is crucial for cancer research.

The clearance enables ABILITY Neurotech to move beyond intra-operative testing to long-term clinical investigation involving human participants.

Abbott (NYSE:ABT) announced today that it received CE mark approval for its dual glucose-ketone sensing technology for people with diabetes.

Engineers at the University of California San Diego have created a soft, wearable ultrasound patch that can continuously monitor a fetus for hours at a time—and it can do so consistently even as the fetus and umbilical cord constantly move during pregnancy.